Page last updated: 2024-11-13
3-azido-7-hydroxycoumarin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
3-azido-7-hydroxycoumarin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 25127608 |
| CHEMBL ID | 3914775 |
| SCHEMBL ID | 13537338 |
| MeSH ID | M0494131 |
Synonyms (24)
| Synonym |
|---|
| FT-0650711 |
| 3-azido-7-hydroxy-1-benzopyran-2-one |
| 3-azido-7-oxidanyl-chromen-2-one |
| A840193 |
| 817638-68-9 |
| 3-azido-7-hydroxycoumarin |
| 3-azido-7-hydroxy-2h-chromen-2-one |
| AKOS015853801 |
| c9h5n3o3 |
| SCHEMBL13537338 |
| KKJNQKVCZCNJDI-UHFFFAOYSA-N |
| 3-azido-7-hydroxy coumarin |
| 3-azido-7-hydroxy-2h-1-benzopyran-2-one |
| 3-azido-7-hydroxy-chromen-2-one |
| A1-09479 |
| CHEMBL3914775 |
| 2h-1-benzopyran-2-one, 3-azido-7-hydroxy- |
| DTXSID80648782 |
| GS-6326 |
| mfcd12924840 |
| 3-azido-7-hydroxychromen-2-one |
| E78957 |
| BP-27945 |
| F05-0022 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (5)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1325324 | Cytotoxicity against human HeLa cells after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22 | Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds. |
| AID1325325 | Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22 | Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds. |
| AID1325328 | Selectivity factor, ratio of IC50 for human MRC5 cells to IC50 for human MCF7 cells | 2016 | Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22 | Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds. |
| AID1325327 | Selectivity factor, ratio of IC50 for human MRC5 cells to IC50 for human HeLa cells | 2016 | Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22 | Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds. |
| AID1325326 | Cytotoxicity against human MRC5 cells after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22 | Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 27.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.36) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||